XML 42 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Selected Quarterly Financial Data (Unaudited)
 12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Financial Data (Unaudited)
SELECTED QUARTERLY FINANCIAL DATA (Unaudited)
The following table provides the selected quarterly financial data for 2015 and 2014 (in thousands, except per share amounts):
SOLAZYME, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
Quarter Ended
 
December 31,
2015
 
September 30,
2015
 
June 30,
2015
 
March 31,
2015
 
December 31,
2014
 
September 30,
2014
 
June 30,
2014
 
March 31,
2014
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Product revenue
$
7,039

 
$
9,133

 
$
8,307

 
$
8,821

 
$
9,353

 
$
11,623

 
$
9,022

 
$
7,348

Research and development programs
3,348

 
2,266

 
3,433

 
3,784

 
5,149

 
5,936

 
6,917

 
5,043

Total revenues
10,387

 
11,399

 
11,740

 
12,605

 
14,502

 
17,559

 
15,939

 
12,391

Costs and operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of product revenue
4,578

 
4,570

 
4,361

 
4,670

 
6,154

 
6,598

 
4,470

 
3,390

Research and development
9,586

 
13,207

 
12,747

 
12,554

 
18,210

 
20,571

 
22,064

 
20,835

Sales, general and administrative
18,888

 
19,596

 
20,981

 
21,268

 
22,139

 
25,883

 
21,637

 
20,607

       Restructuring charges
4,581

 
(21
)
 
(31
)
 
424

 
3,514

 
—

 
—

 
—

Total costs and operating expenses
37,633

 
37,352

 
38,058

 
38,916

 
50,017

 
53,052

 
48,171

 
44,832

Loss from operations
(27,246
)
 
(25,953
)
 
(26,318
)
 
(26,311
)
 
(35,515
)
 
(35,493
)
 
(32,232
)
 
(32,441
)
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest and other (expense) income, net
(3,323
)
 
(3,225
)
 
(3,410
)
 
(3,273
)
 
(3,205
)
 
(3,188
)
 
(4,662
)
 
(1,112
)
Loss from equity method investment
(4,098
)
 
(5,916
)
 
(7,309
)
 
(5,066
)
 
(7,724
)
 
(7,201
)
 
(4,278
)
 
(3,834
)
Gain from change in fair value of warrant liability
—

 
—

 
—

 
—

 
—

 
—

 
—

 
688

Gain (loss) from change in fair value of derivative liability
(26
)
 
176

 
(134
)
 
(15
)
 
1,578

 
6,205

 
(1,745
)
 
2,018

Total other income (expense)
(7,447
)
 
(8,965
)
 
(10,853
)
 
(8,354
)
 
(9,351
)
 
(4,184
)
 
(10,685
)
 
(2,240
)
Net loss
(34,693
)
 
(34,918
)
 
(37,171
)
 
(34,665
)
 
(44,866
)
 
(39,677
)
 
(42,917
)
 
(34,681
)
Net loss per share, basic and diluted
$
(0.43
)
 
$
(0.43
)
 
$
(0.46
)
 
$
(0.44
)
 
$
(0.57
)
 
$
(0.50
)
 
$
(0.56
)
 
$
(0.50
)
Weighted-average number of shares used in loss per share computation, basic and diluted
80,600

 
80,298

 
80,098

 
79,650

 
79,330

 
78,867

 
75,963

 
69,213